Apoptotic and proliferative activity in the neoplastic progression of Barrett's oesophagus: a comparative study

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Pathology

• Publication date

  1999-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1096-9896(199904)187:5<535::AID-PATH302>3.0.CO;2-GPMID 10398118
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia

  2005cited by this paper
• Analysis of apoptosis in tissue sections.

  1999cited by this paper
• Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation

  1998cited by this paper
• Reflux Disease and Barrett's Esophagus

  1998cited by this paper
• Regulation and Significance of Apoptosis in the Stem Cells of the Gastrointestinal Epithelium

  1997cited by this paper
• Cellular kinetics in Barrett's epithelium carcinogenic sequence: roles of apoptosis, bcl-2 protein, and cellular proliferation.

  1997cited by this paper
• The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.

  1997cited by this paper
• The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.

  1997cited by this paper
• Epithelial cell growth and differentiation. II. Intestinal apoptosis.

  1997cited by this paper
• Increased apoptosis accompanies neoplastic development in the human colorectum.

  1996cited by this paper
• Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma.

  1996cited by this paper
• The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett.

  1996cited by this paper
• Assessment of PCNA (19A2) and Ki-67 (MIB1) Cell Proliferation Markers in Formalin Fixed Tissues

  1995cited by this paper
• Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma.

  1995cited by this paper
• Inhibition of apoptosis during development of colorectal cancer.

  1995cited by this paper
• Expansion of the Ki‐67 proliferative compartment correlates with degree of Dysplasia in Barrett's esophagus

  1995cited by this paper
• Early detection and treatment of oesophageal and gastric cancer. The Rotterdam Oesophageal Tumour Study Group.

  1995cited by this paper
• Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas

  1995cited by this paper
• Early detection and treatment of oesophageal and gastric cancer

  1995cited by this paper
• Apoptosis and cancer: the failure of controls on cell death and cell survival.

  1995cited by this paper
• Disruption of epithelial cell-matrix interactions induces apoptosis

  1994cited by this paper
• Barrett's oesophagus and markers of malignant potential

  1994cited by this paper
• Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis.

  1994cited by this paper
• Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation.

  1993cited by this paper
• Risk factors for the development of an adenocarcinoma in columnar‐lined (Barrett) esophagus

  1993cited by this paper
• Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression.

  1993cited by this paper
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

  1992cited by this paper

• Synergic effect of bee pollen and metformin on proliferation and apoptosis of granulosa cells: Rat model of polycystic ovary syndrome.

  2021cites this paper
• Histological assessment & use of immunohistochemical markers for detection of dysplasia in Barrett's esophageal mucosa.

  2018cites this paper
• Gastroesophageal Mucosal Injury after Cholecystectomy: An Indication for Surveillance?

  2017cites this paper
• The Columnar Lined Esophagus: aspects on the assessment of dysplasia and on the relationship with the esophageal submucosal glands

  2015cites this paper
• Role of interleukin-6 in Barrett's esophagus pathogenesis.

  2013cites this paper
• 5. Barrett's Oesophagus

  2012cites this paper
• Curcumin abrogates bile-induced NF-κB activity and DNA damage in vitro and suppresses NF-κB activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett’s oesophagus

  2012cites this paper
• The Immune Cell Composition in Barrett's Metaplastic Tissue Resembles That in Normal Duodenal Tissue

  2012cites this paper
• Relationship between apoptosis and proliferation in granulosa and theca cells of cystic follicles in sows.

  2012cites this paper
• Delineating the pro-carcinogenic pathways activated by obesity in Barrett's oesophagus

  2011cites this paper
• The resistance of esophageal adenocarcinoma to bile salt insult is associated with manganese superoxide dismutase expression.

  2011cites this paper
• The effect of fundoplication on proliferative and anti‐apoptotic activity of esophageal mucosa in gastroesophageal reflux disease: 4‐year follow‐up study

  2011cites this paper
• Proliferative and Anti-Apoptotic Activity of Esophageal Mucosa in Gastroesophageal Reflux Disease Is Not Affected by Fundoplication: A 4-Year Follow-Up Study

  2011cites this paper
• Genomic instability in patients with Barrett's esophagus.

  2010influential citation
• Reflux esophagitis, high-grade neoplasia, and early Barrett’s carcinoma—what is the place of the Merendino procedure?

  2009cites this paper
• Apoptosis in Carcinogenesis and Chemotherapy

  2009cites this paper
• Usefulness of histopathological markers in diagnosing Barrett's intraepithelial neoplasia (dysplasia).

  2009cites this paper
• Apoptosis in Carcinogenesis and Chemotherapy – Esophageal Cancer

  2009cites this paper
• Understanding Barrett's oesophagus, part 1: Surveillance and management

  2009cites this paper
• Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett’s esophagus

  2008cites this paper
• Early Barrett's carcinoma of the esophagus.

  2008cites this paper
• Defining Cancer Risk in Barrett's Esophagus: A Pathologist's Perspective.

  2008cites this paper
• Multistage carcinogenesis in Barrett's esophagus.

  2007cites this paper
• Alterations in Manganese Superoxide Dismutase Expression in the Progression From Reflux Esophagitis to Esophageal Adenocarcinoma

  2007cites this paper
• NEOPLASTIC RISK ASSESSMENT IN BARRETT’S ESOPHAGUS

  2007cites this paper
• Pathology of Reflux Disease at a Cellular Level: Part 3—Intestinal (Barrett) Metaplasia to Carcinoma

  2006cites this paper
• Identification of clinically-informative biomarkers within the spectrum of gastro-oesophageal reflux disease in the South African population

  2006influential citation
• Influence of acid and bile acid on ERK activity, PPARgamma expression and cell proliferation in normal human esophageal epithelial cells.

  2006cites this paper
• Esophageal acid exposure at pH ≤ 2 is more common in Barrett's esophagus patients and is associated with oxidative stress.

  2006cites this paper
• PREVALENCE OF p21 IMMUNOHISTOCHEMICAL EXPRESSION IN ESOPHAGEAL

  2006cites this paper
• Prevalence of p21 immunohistochemical expression in esophageal adenocarcinoma.

  2006cites this paper
• Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States)

  2006cites this paper
• Esophageal acid exposure at pH < or = 2 is more common in Barrett's esophagus patients and is associated with oxidative stress.

  2006cites this paper
• Molecular basis of Barrett’s oesophagus and oesophageal adenocarcinoma

  2006cites this paper
• Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.

  2006cites this paper
• Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus.

  2005influential citation
• Gastroesophageal reflux and cancer.

  2005cites this paper
• Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.

  2005cites this paper
• p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations.

  2005cites this paper
• Esomeprazole tablet vs omeprazole capsule in treating erosive esophagitis.

  2005cites this paper
• New molecular concepts of Barrett's esophagus: clinical implications and biomarkers.

  2005cites this paper
• Ki67 and p53 immunohistochemistry reduces interobserver variation in assessment of Barrett's oesophagus

  2005cites this paper
• Daily Variations in Colchicine‐Induced Apoptosis in Duodenal Crypts

  2005cites this paper
• Ki67 expression in different epithelial types in columnar lined oesophagus indicates varying levels of expanded and aberrant proliferative patterns

  2005cites this paper
• Tissue inhibitor of metalloproteinase‐3 (TIMP‐3) gene is methylated in the development of esophageal adenocarcinoma: Loss of expression correlates with poor prognosis

  2005cites this paper
• The molecular biology of esophageal adenocarcinoma

  2005cites this paper
• PREVALÊNCIA DA EXPRESSÃO IMUNOISTOQUÍMICA DA PROTEÍNA p21 EM ADENOCARCINOMA DO ESÔFAGO.

  2004cites this paper
• The light solution for Barrett's oesophagus Photodiagnosis and photodynamic therapy for columnar-lined oesophagus.

  2004cites this paper
• In Vitro Acid Exposure has a Differential Effect on Apoptotic and Proliferative Pathways in a Barrett's Adenocarcinoma Cell Line

  2004cites this paper
• Biomarkers of Esophageal Adenocarcinoma and Barrett’s Esophagus

  2004cites this paper
• C-erb-B2 and Bcl-xl protein expression in Barrett's oesophagus in correlation with morphological parameters.

  2004cites this paper
• Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett’s Esophagus

  2004cites this paper
• Phenotypic differences between esophageal and gastric intestinal metaplasia

  2004cites this paper
• Clinical and molecular pathology of the metaplasia–dysplasia–carcinoma sequence in Barrett's oesophagus

  2003cites this paper
• Estudo da pele fotoenvelhecida antes e após esfoliação química com o ácido pirúvico a 80%: análise clínica, histopatológica e imunohistoquímica da proliferação celular

  2003cites this paper
• COX-2 inhibition in esophagitis, Barrett's esophagus and esophageal cancer.

  2003cites this paper
• Histological features pertinent to local tumour progression in Barrett's adenocarcinoma.

  2003cites this paper
• Association of Metallothionein Expression and Lack of Apoptosis with Progression of Carcinogenesis in Barrett's Esophagus

  2003cites this paper
• Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas.

  2002cites this paper
• Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma.

  2002cites this paper
• Role of molecular biology in the follow-up of patients who have Barrett's esophagus.

  2002cites this paper
• Apoptosis in Barrett's oesophagus following antireflux surgery

  2002cites this paper
• DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis.

  2002cites this paper
• Direct Correlation between Proliferative Activity and Dysplasia in Pancreatic Intraepithelial Neoplasia (PanIN): Additional Evidence for a Recently Proposed Model of Progression

  2002cites this paper
• Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype.

  2002cites this paper
• Immunohistochemical markers of cell immortality.

  2002cites this paper
• The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.

  2002cites this paper
• Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus.

  2002cites this paper
• Expression of cyclin B1 in the metaplasia‐dysplasia‐carcinoma sequence of Barrett esophagus

  2002influential citation
• Proliferative Activity in Barrett’s Esophagus Before and After Antireflux Surgery

  2001cites this paper
• The Metaplasia-Dysplasia-Carcinoma Sequence of Barrett’s Esophagus

  2001cites this paper
• The Role of Ablation in the Management of High-Grade Dysplasia

  2001cites this paper
• Adenocarcinomas of the gastro-oesophageal junction : from gene to clinic

  2001cites this paper
• Molecular Alterations of Barrett’s Esophagus on Microdissected Endoscopic Biopsies

  2001cites this paper
• Barrett's oesophagus and proton pump inhibitors: a pathological perspective

  2000cites this paper
• Field defects in progression to adenocarcinoma of the colon and esophagus

  2000cites this paper
• Apoptosis, proliferation, and angiogenesis in oral tissues. Possible relevance to tumour progression

  2000cites this paper
• Immunocytochemical study of cell proliferation in the cystic ovarian follicles in cows.

  2000cites this paper
• C-erb-B 2 and Bcl-xl protein expression in Barrett ́ s oesophagus in correlation with morphological parameters

  year unknowncites this paper
• The Effect of Selective Cyclooxygenase-2 Inhibition in Barrett's Esophagus Epithelium: an in Vitro Study Methods: Primary Esophageal Ep- Ithelial and Fibroblast Cell Cultures Were Established from Endoscopic Biopsy Specimens from 20 Consecutive Patients with Barrett's Esophagus. Cox-2 Expression and

  year unknowncites this paper